Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Yiaco Medical Co (YIACO) - Financial and Strategic SWOT Analysis Review
Yiaco Medical Co (YIACO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More
-
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Berger's Disease therapeutics. More than 100,000 incident cases of Berger’s Dis ... Read More
-
United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030 Summary GlobalData’s “United Kingdom Minimally Invasive Neurosurgery Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Minimally Invasive Neurosu ... Read More
-
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top C ... Read More
-
Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor T ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Trial Phase, Trial Status, ... Read More
-
Apotex Inc - Strategic SWOT Analysis Review
Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T ... Read More
-
Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review
Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More
-
Sanofi S.A - Digital Transformation Strategies
Sanofi S.A - Digital Transformation Strategies Summary This report provides insight into Sanofi's digital technology activities, including its digital transformation strategies, its accelerators, incubators, and other innovation programs, its technology initiatives, venture arm, investments, and its ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review
WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an ... Read More
-
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End P ... Read More
-
Polycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Polycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and T ... Read More
-
Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, a ... Read More
-
Allergic Rhino-Conjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Allergic Rhino-Conjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Allergic Rhino-Conjunctivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Typ ... Read More
-
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, ... Read More
-
Amyloidosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Amyloidosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Amyloidosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update pr ... Read More
-
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Neurovascular Accessory Devices Pipeline Report including Stages of Development, Segmen ... Read More
-
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026 Summary The report provides an in-depth assessment of the COVID-19 market including disease ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DLBCL therapeutics. More than 555,000 diagnosed prevalent cases of DLBCL are ... Read More
-
Beiersdorf - Company Overview and Analysis, 2023 Update
Beiersdorf - Company Overview and Analysis, 2023 Update Summary Beiersdorf - Company Overview and Analysis, 2023 Update, reports key findings as of 18th September, 2023 based on market analysis and brand diversification by industry and geography. Beiersdorf AG (Beiersdorf) has presence in the cosmet ... Read More
-
DR. VEGAN - How a Vegan Supplements Brand has Achieved Success by Leveraging Sustainable and Ethical Principles
DR. VEGAN - How a Vegan Supplements Brand has Achieved Success by Leveraging Sustainable and Ethical Principles Summary This report explores how a vegan supplements brand has achieved success by leveraging sustainable and ethical principles DR.VEGAN is a vegan supplements brand addressing various fa ... Read More
-
Bayer AG - Company Overview and Analysis, 2023 Update
Bayer AG - Company Overview and Analysis, 2023 Update Summary Bayer AG - Company Overview and Analysis, 2023 Update, reports key findings as of 18th August, 2023 based on market analysis and brand diversification by industry and geography. Bayer AG (Bayer) is a German multinational pharmaceutical an ... Read More
-
United States (US) Dura Substitute Procedures Count by Segments (Craniotomy Dura Substitute Procedures and Spinal Dura Substitute Procedures) and Forecast to 2030
United States (US) Dura Substitute Procedures Count by Segments (Craniotomy Dura Substitute Procedures and Spinal Dura Substitute Procedures) and Forecast to 2030 Summary GlobalData’s “United States Dura Substitute Procedures Outlook to 2030” is a comprehensive databook report, covering key procedur ... Read More
Research Assistance
